Medicinals for the Millennia
10.1111/j.1749-6632.2001.tb11356.x
Crossref journal-article
Wiley
Annals of the New York Academy of Sciences (311)
Abstract

Abstract: Nature has been a source of medicinal agents for thousands of years, and an impressive number of modern drugs have been isolated from natural sources, many based on their use in traditional medicine. The use of herbal drugs is once more escalating in the form of complementary and alternative medicine. The past century, however, has seen an increasing role played by microorganisms in the production of the antibiotics and other drugs for the treatment of some serious diseases. With less than 1% of the microbial world currently known, advances in procedures for microbial cultivation and the extraction of nucleic acids from environmental samples from soil and marine habitats, and from symbiotic and endophytic microbes associated with terrestrial and marine macro‐organisms, will provide access to a vast untapped reservoir of genetic and metabolic diversity. By use of combinatorial chemical and biosynthetic technology, novel natural product leads will be optimized on the basis of their biological activities to yield effective chemotherapeutic and other bioactive agents.

Bibliography

CRAGG, G. M., & NEWMAN, D. J. (2001). Medicinals for the Millennia. Annals of the New York Academy of Sciences, 953a(1), 3–25. Portico.

Authors 2
  1. GORDON M. CRAGG (first)
  2. DAVID J. NEWMAN (additional)
References 90 Referenced 78
  1. Anonymous. 1998. A Pictorial History of Herbs in Medicine and Pharmacy. Herbalgram: 33‐47.
  2. Kapoor L.D. 1990. CRC Handbook of Ayurvedic Medicinal Plants. CRC Press. Boca Raton FL.
  3. {'key': 'e_1_2_4_4_2', 'first-page': '38', 'volume': '31', 'author': 'Fallarino M.', 'year': '1994', 'journal-title': 'Herbalgram'} / Herbalgram by Fallarino M. (1994)
  4. Chang H.‐M. & P.P.‐H. But. 1986. Pharmacology and Applications of Chinese Materia Medica. World Scientific Publishing. Singapore.
  5. Iwu M.M. 1993. Handbook of African Medicinal Plants. CRC Press. Boca Raton FL.
  6. Jain S.K. 1991. Medicinal Plants of India. Reference Publications. Algonac MI.
  7. Arvigo R. & M. Balick. 1993. Rainforest Remedies. Lotus Press. Twin Lakes WI.
  8. Ayensu E.S. 1981. Medicinal Plants of the West Indies. Reference Publications. Algonac MI.
  9. Gupta M.P. 1995. 270 Plantas Medicinales Iberoamericanas. CYTED. Bogota Colombia.
  10. Schultes R.E. & R.F. Raffauf. 1990. The Healing Forest. Dioscorides Press. Portland OR.
  11. {'key': 'e_1_2_4_12_2', 'first-page': '965', 'article-title': 'Medicinal plants in therapy', 'volume': '63', 'author': 'Farnsworth N.R.', 'year': '1985', 'journal-title': 'Bull. WHO'} / Bull. WHO / Medicinal plants in therapy by Farnsworth N.R. (1985)
  12. Buss A.D. & R.D. Waigh. 1995. Natural products as leads for new pharmaceuticals. In Burgers Medicinal Chemistry and Drug Discovery fifth ed. Vol. 1. M.E. Wolff Ed.: 983‐1033. John Wiley. New York.
  13. Mann J. 1994.InMurder Magic and Medicine. Oxford University Press. Oxford U.K. pp. 164‐170.
  14. Musser J.H. P. Fugedi & M.B. Anderson. 1995. Carbohydrate‐based therapeutics.InBurgers Medicinal Chemistry and Drug Discovery. Vol. 1 5th ed. M.E. Wolff Ed.: 901‐947. John Wiley & Sons. New York.
  15. Hartwell J.L. 1982. Plants Used Against Cancer. Quarterman. Lawrence MA.
  16. Cragg G.M. M.R. Boyd J.H. Cardellina et al.1994. Ethnobotany and the Search for New Drugs.InCiba Foundation Symposium. Vol. 185. D.J. Chadwick & J. Marsh Eds.: 178‐196. Wiley & Sons. Chichester UK.
  17. {'key': 'e_1_2_4_18_2', 'first-page': '1657', 'article-title': 'The taxol supply crisis', 'volume': '56', 'author': 'Cragg G.M.', 'year': '1993', 'journal-title': 'New NCI policies for handling the large-scale production of novel natural product anticancer and anti-HIV agents. J. Nat. Prod.'} / New NCI policies for handling the large-scale production of novel natural product anticancer and anti-HIV agents. J. Nat. Prod. / The taxol supply crisis by Cragg G.M. (1993)
  18. 10.1200/JCO.1995.13.10.2643
  19. Potmeisel M. & H. Pinedo. 1995. Camptothecins: New Anticancer Agents. CRC Press. Boca Raton FL.
  20. Scriabine A. 1999. Discovery and development of major drugs currently in use.InPharmaceutical Innovation. R. Landau B. Achilladelis & A. Scriabine Eds.: 148‐270. Chemical Heritage Press.
  21. 10.2165/00003495-199754060-00003
  22. Tyler V.E. 1993. The Honest Herbal. Haworth Press. New York.
  23. Tyler V.E. 1994. Herbs of Choice. Haworth Press. New York.
  24. 10.1289/ehp.99107773 / Environ. Health Perspec. / Medicinal Herbs in the United States by Matthews H.B. (1999)
  25. Wichtl M. 1994. Herbal Drugs and Phytopharmaceuticals. Medpharm Scientific Publishers. Stuttgart Germany.
  26. De Smet P.A.G.M. 1992. Adverse Effects of Herbal Drugs. Springer‐Verlag. Berlin. (10.1007/978-3-642-49340-9)
  27. 10.1126/science.284.5416.974
  28. Foye W.O. 1995. Cancer Chemotherapeutic Agents. American Chemical Society. Washington DC.
  29. Margulis L. & K.V. Schwartz. 1988. Five Kingdoms: An Illustrated Guide to the Phyla of Life on Earth. 2nd ed. W. H. Freeman & Co. New York.
  30. McConnell O. R.E. Longley & F.E. Koehn. 1994. The discovery of marine natural products with therapeutic potential.InThe Discovery of Natural Products with Therapeutic Potential. V.P. Gullo Ed.: 109‐174. Butterworth‐Heinemann. Boston. (10.1016/B978-0-7506-9003-4.50011-3)
  31. 10.1039/a809395d
  32. {'key': 'e_1_2_4_33_2', 'first-page': '271', 'article-title': 'Biomedical potential of marine natural products', 'volume': '46', 'author': 'Carte B.K.', 'year': '1996', 'journal-title': 'Bio-Science'} / Bio-Science / Biomedical potential of marine natural products by Carte B.K. (1996)
  33. Newman D.J. 1996. Bryostatin—from bryozoan to cancer drug.In10th International Bryozoology Conference. D. P. Gordon A.M. Smith & J.A. Grant‐Mackie Eds.: 9‐17. National Institute of Water & Atmospheric Research. Wellington N.Z.
  34. 10.1093/jnci/85.22.1812
  35. 10.1021/np010049y
  36. 10.1016/S0168-1656(99)00052-8
  37. Zheng W. B.M. Seletsky M.H. Palme et al.2000. Synthetic macrocyclic ketone analogs of halichondrin B: structure‐activity relationships. Proc. Am. Soc. Cancer Res. Abstr. 1915. 91st Annual Meeting of the American Association of Cancer REseaarch April 1‐5 2000 San Francisco.
  38. Towle M.J. K.A. Salvato J. Budrow et al.2000. Highly potentin vitroandin vivoanticancer activities of synthetic macrocyclic ketone analogs of halichondrin B. Proc. Am. Soc. Cancer Res. Abstr. 1370. 91st Annual Meeting of the American Association of Cancer REseaarch April 1‐5 2000 San Francisco.
  39. 10.1021/bi9515127
  40. {'key': 'e_1_2_4_41_2', 'first-page': '1111', 'article-title': 'Eleutherobin, a novel cytotoxic agent that induces tubulin polymerization, is similar to paclitxel', 'volume': '58', 'author': 'Long B.H.', 'year': '1998', 'journal-title': 'Cancer Res.'} / Cancer Res. / Eleutherobin, a novel cytotoxic agent that induces tubulin polymerization, is similar to paclitxel by Long B.H. (1998)
  41. 10.1111/j.1749-6632.1999.tb08883.x
  42. 10.1021/np970460e
  43. 10.1039/a902202c
  44. 10.1021/np9604893
  45. 10.1029/93RG01280
  46. 10.1038/371663a0
  47. Balandrin M.F. A.D. Kinghorn & N.R. Farnsworth. 1993. Plant‐derived natural products in drug discovery and development: an overview.InHuman Medicinal Agents from Plants American Chemical Society Symposium Series No. 534. A.D. Kinghorn & M.F. Balandrin Eds.: 2‐12. American Chemical Society. Washington DC. (10.1021/bk-1993-0534.ch001)
  48. {'key': 'e_1_2_4_49_2', 'first-page': '417', 'article-title': 'Major microbial diversity initiative recommended', 'volume': '63', 'author': 'Young P.', 'year': '1997', 'journal-title': 'ASM News'} / ASM News / Major microbial diversity initiative recommended by Young P. (1997)
  49. 10.1016/S1074-5521(98)90108-9
  50. 10.1038/nbt0698-593
  51. 10.1126/science.280.5372.2073
  52. 10.1016/S0167-7799(98)01193-7
  53. 10.1038/sj.jim.2900390
  54. 10.1073/pnas.96.7.3336
  55. 10.1021/jo000849y
  56. 10.1039/a909079g
  57. 10.1126/science.284.5413.482
  58. 10.1016/S1074-5521(00)00075-2
  59. 10.1016/S0378-1119(00)00149-9
  60. Metcalf B. 2001. The genetic manipulation of polyketide gene clusters as an approach to drug discovery. Presentation at the Asian Federation of Medicinal Chemistry 01 Brisbane Australia.
  61. Frykman S. R. Regentin J. Lau et al.2001. Development of a scalable epothilone D fermentation process using a heterologous host. Presenttion at the Society for Industrial Microbiology Annual Meeting St. Louis MO.
  62. 10.1126/science.285.5425.186
  63. 10.1073/pnas.85.19.7197
  64. 10.1073/pnas.96.7.3496
  65. 10.1002/(SICI)1521-3773(19980817)37:15<2014::AID-ANIE2014>3.0.CO;2-2
  66. Vite G.D. R.M. Borzilleri S‐H. Kim & J.A. Johnson. 1999. U.S. Patent WO99/02514; PCT/US98/12550.
  67. 10.1021/ja001899n
  68. {'key': 'e_1_2_4_69_2', 'first-page': '4369', 'article-title': 'On the interactivity of complex synthesis and tumor pharmacology in the drug discovery process: total synthesis and comparative in vivo evaluations of the 15‐aza_epothilones', 'volume': '66', 'author': 'Stachel S.W.', 'year': '2001', 'journal-title': 'J. Am. Chem. Soc.'} / J. Am. Chem. Soc. / On the interactivity of complex synthesis and tumor pharmacology in the drug discovery process: total synthesis and comparative in vivo evaluations of the 15‐aza_epothilones by Stachel S.W. (2001)
  69. 10.1073/pnas.96.8.4256
  70. 10.1073/pnas.040546297
  71. 10.1002/1439-7633(20010105)2:1<69::AID-CBIC69>3.0.CO;2-8
  72. Borman S. 2001. Combinatorial chemistry. C&EN August 27 2001:49‐58. (10.1021/cen-v079n035.p049)
  73. 10.1002/(SICI)1521-3773(19980605)37:10<1418::AID-ANIE1418>3.0.CO;2-5
  74. {'key': 'e_1_2_4_75_2', 'first-page': '9968', 'article-title': 'Natural product‐like combinatorial libraries based on privileged structures', 'volume': '122', 'author': 'Nicolaou K.C.', 'year': '2000', 'journal-title': '3. The “libaries from libraries” principle for diversity enhancement of benzopyran libraries. J. Am. Chem. Soc.'} / 3. The “libaries from libraries” principle for diversity enhancement of benzopyran libraries. J. Am. Chem. Soc. / Natural product‐like combinatorial libraries based on privileged structures by Nicolaou K.C. (2000)
  75. 10.1021/ja002034c
  76. {'key': 'e_1_2_4_77_2', 'first-page': '9939', 'article-title': 'Natural product‐like combinatorial libraries based on privileged structures', 'volume': '122', 'author': 'Nicolaou K.C.', 'year': '2000', 'journal-title': '1. General prinicples and solid-phase synthesis of benzopyrans. J. Am. Chem. Soc.'} / 1. General prinicples and solid-phase synthesis of benzopyrans. J. Am. Chem. Soc. / Natural product‐like combinatorial libraries based on privileged structures by Nicolaou K.C. (2000)
  77. 10.1039/a804795b
  78. 10.1002/1521-3765(20010903)7:17<3798::AID-CHEM3798>3.0.CO;2-6
  79. 10.1016/S0968-0896(98)00126-6
  80. 10.1021/ja981746o
  81. 10.1021/ja016093h
  82. Sausville E.A. 1997. Targeted toxins.InEncyclopedia of Cancer. Vol. III. J. Bertino Ed.: 1703‐1714. Academic Press. San Diego.
  83. 10.1021/cen-v078n011.p047
  84. {'key': 'e_1_2_4_85_2', 'first-page': '7', 'article-title': 'Cancer Lett', 'volume': '15', 'author': 'Anonymous.', 'year': '2000', 'journal-title': 'Bus. Reg. Rep.'} / Bus. Reg. Rep. / Cancer Lett by Anonymous. (2000)
  85. 10.1073/pnas.93.16.8618
  86. Johnson R. 2000. Personal communication with Dr. Randall Johnson SKB Pharmaceutical R & D. Sept. 1 2000.
  87. {'key': 'e_1_2_4_88_2', 'first-page': '83', 'article-title': 'Phase I clinical and pharmacokinetic study of PK1 [N‐(2‐hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents—drug‐polymer conjugates', 'volume': '5', 'author': 'Vasey P.A.', 'year': '1999', 'journal-title': 'Cancer Research Campaign Phase I/II Committee. Clin. Cancer Res.'} / Cancer Research Campaign Phase I/II Committee. Clin. Cancer Res. / Phase I clinical and pharmacokinetic study of PK1 [N‐(2‐hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents—drug‐polymer conjugates by Vasey P.A. (1999)
  88. 10.1016/S0168-3659(98)00124-2
  89. 10.1093/jnci/88.3-4.153
  90. Horan A.C. 1994. Actinomycetes.InThe Discovery of Natural Products with Therapeutic Potential. V.P. Gullo Ed.: 3‐30. Butterworth‐Heinemann. Boston. (10.1016/B978-0-7506-9003-4.50007-1)
Dates
Type When
Created 19 years, 6 months ago (Feb. 10, 2006, 12:48 p.m.)
Deposited 1 year, 11 months ago (Sept. 25, 2023, 1:44 p.m.)
Indexed 6 days, 9 hours ago (Aug. 27, 2025, 11:44 a.m.)
Issued 23 years, 9 months ago (Dec. 1, 2001)
Published 23 years, 9 months ago (Dec. 1, 2001)
Published Online 19 years, 6 months ago (Feb. 10, 2006)
Published Print 23 years, 9 months ago (Dec. 1, 2001)
Funders 0

None

@article{CRAGG_2001, title={Medicinals for the Millennia: The Historical Record}, volume={953a}, ISSN={1749-6632}, url={http://dx.doi.org/10.1111/j.1749-6632.2001.tb11356.x}, DOI={10.1111/j.1749-6632.2001.tb11356.x}, number={1}, journal={Annals of the New York Academy of Sciences}, publisher={Wiley}, author={CRAGG, GORDON M. and NEWMAN, DAVID J.}, year={2001}, month=dec, pages={3–25} }